Castle Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.12 M | $88.99 M | 100.00% | 11.21% |
| WASATCH ADVISORS LP | 11/14/2024 | 1.83 M | $52.08 M | -21.56% | 6.56% |
| VANGUARD GROUP INC | 11/13/2024 | 1.75 M | $49.87 M | 10.85% | 6.28% |
| PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 1.54 M | $43.88 M | 2.70% | 5.53% |
| BELLEVUE GROUP AG | 11/14/2024 | 1.26 M | $35.99 M | 3.69% | 4.53% |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.26 M | $35.81 M | 3.69% | 4.51% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 864,821 | $24.66 M | 6.78% | 3.11% |
| STATE STREET CORP | 11/14/2024 | 680,001 | $19.39 M | 9.84% | 2.44% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 662,332 | $18.89 M | -22.41% | 2.38% |
| CITADEL ADVISORS LLC | 11/14/2024 | 633,016 | $18.05 M | -8.71% | 2.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 624,683 | $17.82 M | 1.13% | 2.24% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 542,593 | $15.47 M | 89.38% | 1.95% |
| PALISADE CAPITAL MANAGEMENT, LP | 11/14/2024 | 502,317 | $14.33 M | -6.63% | 1.80% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 499,192 | $14.24 M | 828.26% | 1.79% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 496,521 | $14.16 M | -4.14% | 1.78% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 489,562 | $13.96 M | 62.38% | 1.76% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 425,220 | $12.13 M | -59.84% | 1.53% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 10/31/2024 | 407,238 | $11.61 M | -24.98% | 1.46% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 401,238 | $11.44 M | 43.05% | 1.44% |
| MORGAN STANLEY | 11/14/2024 | 396,919 | $11.32 M | 59.16% | 1.43% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 349,229 | $9.96 M | 18.78% | 1.25% |
| BRAIDWELL LP | 11/14/2024 | 331,986 | $9.47 M | -20.21% | 1.19% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 296,071 | $8.44 M | 6.54% | 1.06% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 274,761 | $7.84 M | 16.75% | 0.99% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 242,800 | $6.92 M | 11.82% | 0.87% |
| NEXT CENTURY GROWTH INVESTORS LLC | 11/14/2024 | 234,091 | $6.68 M | -1.16% | 0.84% |
| MARSHALL WACE, LLP | 11/14/2024 | 220,797 | $6.30 M | 4.13% | 0.79% |
| INTRINSIC EDGE CAPITAL MANAGEMENT LLC | 11/08/2024 | 212,711 | $6.07 M | -16.39% | 0.76% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 11/14/2024 | 201,921 | $5.76 M | 100.00% | 0.73% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 201,747 | $5.75 M | 153.41% | 0.72% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 190,570 | $5.44 M | 106.08% | 0.68% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 183,931 | $5.25 M | -2.02% | 0.66% |
| ADVISORS CAPITAL MANAGEMENT, LLC | 11/14/2024 | 167,927 | $4.79 M | 18.01% | 0.60% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 165,458 | $4.72 M | 147.37% | 0.59% |
| SHELTON CAPITAL MANAGEMENT | 11/14/2024 | 164,008 | $4.68 M | 100.00% | 0.59% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 159,624 | $4.55 M | 274.26% | 0.57% |
| LISANTI CAPITAL GROWTH, LLC | 11/04/2024 | 154,710 | $4.41 M | 60.24% | 0.56% |
| HARBOR CAPITAL ADVISORS, INC. | 10/29/2024 | 153,907 | $4.39 M | 10.96% | 0.55% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 140,537 | $4.01 M | 303.53% | 0.50% |
| ALGERT GLOBAL LLC | 11/12/2024 | 134,321 | $3.83 M | 0.45% | 0.48% |
| JANE STREET GROUP, LLC | 11/15/2024 | 134,284 | $3.83 M | 262.69% | 0.48% |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 11/15/2024 | 88,908 | $2.54 M | 0.00% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 76,578 | $2.18 M | -20.80% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 72,900 | $2.08 M | 118.26% | 0.26% |
| ORION PORTFOLIO SOLUTIONS, LLC | 11/15/2024 | 72,405 | $2.06 M | 16.63% | 0.26% |
| ALLIANZ ASSET MANAGEMENT GMBH | 11/13/2024 | 70,553 | $2.01 M | 100.00% | 0.25% |
| JPMORGAN CHASE & CO | 12/26/2024 | 69,409 | $1.98 M | 165.24% | 0.25% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 69,382 | $2.38 M | 87.33% | 0.25% |
| ENVESTNET ASSET MANAGEMENT INC | 11/07/2024 | 67,386 | $1.92 M | 43.08% | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 11/14/2024 | 62,868 | $1.79 M | -59.01% | 0.23% |
Castle Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 222 institutional investors and hedge funds held shares of Castle Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 3.12 M
WASATCH ADVISORS LP: 1.83 M
VANGUARD GROUP INC: 1.75 M
PRINCIPAL FINANCIAL GROUP INC: 1.54 M
Bellevue Group AG: 1.26 M
Portolan Capital Management, LLC: 1.26 M
92.51% of Castle Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.22 M shares in the last 24 months. This purchase volume represents approximately $819.28 M in transactions.